SCHEMBL29527151

SCHEMBL29527151

COc1ncc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)cc1C1CCC1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
THRB P10828 19/20 0.49
THRA P10827 16/20 0.49
CYP2C8 P10632 1/20 0.49
CYP2C9 P11712 1/20 0.49
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
OPRK1 P41145 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29066209 1.00 THRB (0.49) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL24450109 0.97 THRA (0.51) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL24450107 0.84 THRB (0.50) THRBTHRACYP2C8CYP2C9
SCHEMBL29066213 0.84 THRB (0.54) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL29526700 0.84 THRB (0.54) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL24450031 0.84 THRB (0.51) THRBTHRACYP2C8CYP2C9
SCHEMBL29527043 0.83 THRA (0.52) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL29066258 0.83 THRA (0.52) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL29527177 0.83 THRA (0.64) THRBTHRACYP2C8CYP2C9
SCHEMBL29066175 0.83 THRA (0.64) THRBTHRACYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240730-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS Aligos Therapeutics, Inc. (US) 2023-09-13 EP disclosed
CN-116710443-A 2-pyridones as thyroid hormone receptor modulators 阿利戈斯治疗公司 2023-09-05 CN disclosed
WO-2022099044-A1 2-PYRIDONES AS THYROID HORMONE RECEPTOR MODULATORS ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed